title: Fourier transform infrared spectroscopic imaging parameters describing acid phosphate substitution in biologic hydroxyapatite.
abstract: Acid phosphate substitution into mineralized tissues is an important determinant of their mechanical properties and their response to treatment. This study identifies and validates Fourier transform infrared spectroscopic imaging (FTIRI) spectral parameters that provide information on the acid phosphate (HPO4) substitution into hydroxyapatite in developing mineralized tissues. Curve fitting and Fourier self-deconvolution were used to identify subband positions in model compounds (with and without HPO4). The intensity of subbands at 1127 and 1110 cm(-1) correlated with the acid phosphate content in these models. Peak height ratios of these subbands to the ν3 vibration at 1096 cm(-1) found in stoichiometric apatite were evaluated in the model compounds and mixtures thereof. FTIRI spectra of bones and teeth at different developmental ages were analyzed using these spectral parameters. Factor analysis (a chemometric technique) was also conducted on the tissue samples and resulted in factor loadings with spectral features corresponding to the HPO4 vibrations described above. Images of both factor correlation coefficients and the peak height ratios 1127/1096 and 1112/1096 cm(-1) demonstrated higher acid phosphate content in younger vs. more mature regions in the same specimen. Maps of the distribution of acid phosphate content will be useful for characterizing the extent of new bone formation, the areas of potential decreased strength, and the effects of therapies such as those used in metabolic bone diseases (osteoporosis, chronic kidney disease) on mineral composition. Because of the wider range of values obtained with the 1127/1096 cm(-1) parameter compared to the 1110/1096 cm(-1) parameter and the smaller scatter in the slope, it is suggested that this ratio should be the parameter of choice.
authors: Hospital for Special Surgery, 535 E. 70th Street, New York, NY 10021, USA.
authors: Lyudmila
authors: L
authors: Spevak
authors: Carol R
authors: CR
authors: Flach
authors: Tracey
authors: T
authors: Hunter
authors: Richard
authors: R
authors: Mendelsohn
authors: Adele
authors: A
authors: Boskey
mesh_terms: D000818:Animals; D015519:Bone Density; D001847:Bone Diseases / Q000378:metabolism; D002130:Calcium Phosphates / Q000737:chemistry; D003804:Dentin / Q000737:chemistry; D017886:Durapatite / Q000737:chemistry*; D006253:Haversian System / Q000502:physiology; D006863:Hydrogen-Ion Concentration; D015233:Models, Statistical; D010215:Papio; D010710:Phosphates / Q000737:chemistry*; D012044:Regression Analysis; D012492:Salts / Q000737:chemistry; D017550:Spectroscopy, Fourier Transform Infrared / Q000379:methods*; D014961:X-Ray Diffraction
chemical_list: D002130:Calcium Phosphates; D010710:Phosphates; D012492:Salts; D017886:Durapatite; C020243:calcium phosphate
references: Methods Mol Biol. 2008;455:293-303
references: 18463826
references: Biomaterials. 2007 May;28(15):2465-78
references: 17175021
references: Hum Mutat. 2011 Jun;32(6):598-609
references: 21344539
references: J Bone Miner Res. 2012 Mar;27(3):672-8
references: 22072397
references: Calcif Tissue Int. 2008 Nov;83(5):342-53
references: 18855037
references: Bone. 2008 Dec;43(6):983-90
references: 18789408
references: Calcif Tissue Int. 1996 Jan;58(1):9-16
references: 8825233
references: Bone. 2005 Jan;36(1):6-12
references: 15663997
references: J Bone Miner Metab. 2010 Jul;28(4):433-45
references: 20091325
references: J Bone Miner Res. 2007 Jul;22(7):1037-45
references: 17402847
references: Calcif Tissue Int. 2009 Mar;84(3):229-39
references: 19172215
references: J Biophotonics. 2009 Feb;2(1-2):13-28
references: 19343682
references: Bone. 2002 Mar;30(3):492-7
references: 11882463
references: J Bone Miner Res. 2009 Jul;24(7):1271-81
references: 19210217
references: Calcif Tissue Int. 1991 Dec;49(6):383-8
references: 1818762
references: Osteoporos Int. 2005 Dec;16(12):2031-8
references: 16088360
references: Anal Bioanal Chem. 2010 Jul;397(6):2491-9
references: 20506017
references: Eur J Oral Sci. 2007 Aug;115(4):296-302
references: 17697169
references: Calcif Tissue Int. 1992 Jan;50(1):42-8
references: 1739869
references: Calcif Tissue Int. 1990 Jun;46(6):384-94
references: 2364326
references: J Res Natl Inst Stand Technol. 2001 Dec 01;106(6):1035-44
references: 27500063
references: J Bone Miner Res. 2010 Jun;25(6):1360-6
references: 20200925
references: Cells Tissues Organs. 2005;181(3-4):144-53
references: 16612080
references: Bone. 2006 Aug;39(2):318-24
references: 16584933
references: Clin Orthop Relat Res. 2011 Aug;469(8):2170-8
references: 21210314
references: J Bone Miner Res. 2001 May;16(5):893-900
references: 11341334
references: Calcif Tissue Int. 1997 Dec;61(6):480-6
references: 9383275
references: Anal Bioanal Chem. 2008 Dec;392(7-8):1479-88
references: 18972105
references: Biophys J. 1991 Oct;60(4):786-93
references: 1660314
references: J Bone Miner Res. 2009 Sep;24(9):1565-71
references: 19419303
references: Bone. 1998 Sep;23(3):187-96
references: 9737340
references: Biochim Biophys Acta. 2001 Jul 2;1527(1-2):11-9
references: 11420138
references: Bone. 2010 May;46(5):1306-15
references: 20117257
references: J Bone Miner Res. 2003 Jun;18(6):955-9
references: 12817747
references: Pharmazie. 2012 May;67(5):457-9
references: 22764582
references: Calcif Tissue Int. 2009 Feb;84(2):126-37
references: 19082853
references: Calcif Tissue Int. 1996 Dec;59(6):480-7
references: 8939775
references: Calcif Tissue Int. 1981;33(2):111-7
references: 6260311
references: Bone. 2010 Jul;47(1):93-101
references: 20362701